Segall Bryant & Hamill LLC Acquires 18,700 Shares of Balchem Corporation (NASDAQ:BCPC)

Segall Bryant & Hamill LLC increased its holdings in shares of Balchem Corporation (NASDAQ:BCPC - Free Report) by 51.1% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 55,316 shares of the basic materials company's stock after purchasing an additional 18,700 shares during the quarter. Segall Bryant & Hamill LLC owned 0.17% of Balchem worth $9,182,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of BCPC. Covestor Ltd boosted its holdings in shares of Balchem by 93.8% in the 4th quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock valued at $26,000 after buying an additional 76 shares during the last quarter. Federated Hermes Inc. acquired a new stake in shares of Balchem in the 4th quarter valued at approximately $33,000. Versant Capital Management Inc boosted its holdings in shares of Balchem by 534.2% in the 1st quarter. Versant Capital Management Inc now owns 241 shares of the basic materials company's stock valued at $40,000 after buying an additional 203 shares during the last quarter. CWM LLC boosted its holdings in shares of Balchem by 34.0% in the 1st quarter. CWM LLC now owns 520 shares of the basic materials company's stock valued at $86,000 after buying an additional 132 shares during the last quarter. Finally, Huntington National Bank boosted its holdings in shares of Balchem by 30.9% in the 4th quarter. Huntington National Bank now owns 661 shares of the basic materials company's stock valued at $108,000 after buying an additional 156 shares during the last quarter. Institutional investors and hedge funds own 87.91% of the company's stock.

Balchem Stock Performance

BCPC traded up $0.18 during trading hours on Monday, reaching $153.02. The company's stock had a trading volume of 125,681 shares, compared to its average volume of 143,675. Balchem Corporation has a 52 week low of $145.70 and a 52 week high of $186.03. The company's 50-day moving average is $163.15 and its 200-day moving average is $162.67. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.40 and a current ratio of 2.44. The firm has a market cap of $4.99 billion, a PE ratio of 36.70, a price-to-earnings-growth ratio of 3.30 and a beta of 0.89.

Balchem (NASDAQ:BCPC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The basic materials company reported $1.22 earnings per share for the quarter, missing the consensus estimate of $1.25 by ($0.03). Balchem had a return on equity of 12.01% and a net margin of 14.16%. The firm had revenue of $250.52 million for the quarter, compared to the consensus estimate of $245.70 million. During the same quarter in the previous year, the business earned $1.03 EPS. The firm's quarterly revenue was up 4.5% on a year-over-year basis. On average, equities analysts forecast that Balchem Corporation will post 4.64 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts have recently commented on BCPC shares. HC Wainwright set a $180.00 price objective on Balchem and gave the company a "buy" rating in a report on Monday, April 28th. Wall Street Zen cut Balchem from a "buy" rating to a "hold" rating in a research note on Wednesday, May 21st.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.